AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 2.520
+0.140 (5.88%)
May 7, 2026, 3:56 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 2.92 billion as of May 7, 2026. Its market cap has decreased by -27.66% in one year.
Market Cap
2.92B
Enterprise Value
4.68B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.52
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 2.92B, a decrease of -85.52%. That is a compound annual growth rate of -41.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 3.09B | -21.50% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 3.83B |
| Clover Biopharmaceuticals | 3.74B |
| TYK Medicines | 3.69B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.57B |
| Antengene Corporation | 3.34B |
| Jiangsu Recbio Technology | 3.20B |
| Medtide | 3.10B |